WHO lists first mpox in vitro diagnostic test under Emergency Use Listing

CHICAGO — Availability of a bevacizumab biosimilar for ophthalmic use could eliminate a lower-cost treatment option for a wide variety of off-label indications and add

The vast majority of U.S. counties are pediatric eye care “deserts,” a cross-sectional study found. Of the more than 3,000 counties in the nation, just

ITM-91 is under clinical development by ITM Isotope Technologies Munich and currently in Phase II for Metastatic Colorectal Cancer.